Jianxia Xiong

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Longitudinal Interferon-γ Release Assay Changes in Psoriasis Treated With Interleukin Inhibitors: A Single-Center Real-World Cohort Study in China.

Longitudinal Interferon-γ Release Assay Changes in Psoriasis Treated With Interleukin Inhibitors: A Single-Center Real-World Cohort Study in China.

Journal: Journal of the American Academy of Dermatology

Published: April 07, 2026

Genotype-Phenotype Correlations and Clinical Outcomes of Spesolimab in Acrodermatitis Continua of Hallopeau: A Multicenter Retrospective Cohort Study.

Genotype-Phenotype Correlations and Clinical Outcomes of Spesolimab in Acrodermatitis Continua of Hallopeau: A Multicenter Retrospective Cohort Study.

Journal: Psoriasis (Auckland, N.Z.)

Published: April 01, 2026

Abrocitinib Treatment of Atopic Dermatitis or Eczema in Patients with Coexistent or Prior Psoriasis: Three Cases with Literature Review.

Abrocitinib Treatment of Atopic Dermatitis or Eczema in Patients with Coexistent or Prior Psoriasis: Three Cases with Literature Review.

Journal: Clinical, cosmetic and investigational dermatology

Published: December 08, 2025

A 76-week real-world multidimensional analysis of guselkumab in moderate to severe plaque psoriasis: a retrospective cohort study based on Chinese clinical practice standards.

A 76-week real-world multidimensional analysis of guselkumab in moderate to severe plaque psoriasis: a retrospective cohort study based on Chinese clinical practice standards.

Journal: Frontiers in immunology

Published: August 13, 2025

Abrocitinib for Head and Neck Dermatitis: Case Series and Literature Review.

Abrocitinib for Head and Neck Dermatitis: Case Series and Literature Review.

Journal: Clinical, cosmetic and investigational dermatology

Published: July 18, 2025

Successful Guselkumab Treatment in a Patient with Comorbid Psoriasis and Amyotrophic Lateral Sclerosis: A Case Study and Literature Review.

Successful Guselkumab Treatment in a Patient with Comorbid Psoriasis and Amyotrophic Lateral Sclerosis: A Case Study and Literature Review.

Journal: Clinical, cosmetic and investigational dermatology

Published: November 27, 2024

Therapeutic potential of monomethyl fumarate and aluminum ion combination in alleviating inflammation and oxidative stress in psoriasis.

Therapeutic potential of monomethyl fumarate and aluminum ion combination in alleviating inflammation and oxidative stress in psoriasis.

Journal: Redox biology

Published: November 12, 2024

Successful guselkumab treatment of a refractory psoriasis patient with Graves' disease: a case report.

Successful guselkumab treatment of a refractory psoriasis patient with Graves' disease: a case report.

Journal: The Journal of international medical research

Published: April 24, 2024

Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.

Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.

Journal: International archives of allergy and immunology

Published: November 07, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026